Accelerate Diagnostics, Inc. (AXDX)

NASDAQ: AXDX · IEX Real-Time Price · USD
3.84 0.12 (3.23%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap267.51M
Revenue (ttm)11.55M
Net Income (ttm)-73.81M
Shares Out69.66M
EPS (ttm)-1.24
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume351,322
Open3.74
Previous Close3.72
Day's Range3.55 - 3.89
52-Week Range3.55 - 15.60
Beta1.80
AnalystsBuy
Price Target8.33 (+116.9%)
Earnings DateFeb 21, 2022

About AXDX

Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic sus...

IndustryLife Sciences Tools & Services
IPO DateNov 18, 1996
CEOJohn Phillips
Employees224
Stock ExchangeNASDAQ
Ticker SymbolAXDX
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 4 analysts, the average rating for AXDX stock is "Buy." The 12-month stock price forecast is 8.33, which is an increase of 116.93% from the latest price.

Price Target
$8.33
(116.93% upside)
Analyst Consensus: Buy

News

Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results

TUCSON, Ariz., Jan. 13, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced preliminary financial results for the quarter and year ending December 31, 2021.

1 week ago - PRNewsWire

Accelerate Diagnostics Wins Suzhou Innovation Award to Support Continued China Commercialization Efforts

TUCSON, Ariz., Jan. 12, 2022 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that it was honored as a recipient of China's Suzhou Industrial Park's (SIP) 15th Science and Tec...

1 week ago - PRNewsWire

Accelerate Diagnostics to Participate Virtually in 40th Annual J. P. Morgan Healthcare Conference on January 13, 2022

TUCSON, Ariz., Dec. 29, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) announced today that the company is scheduled to present at the 40th Annual J.

3 weeks ago - PRNewsWire

Penny Stocks To Buy Now According To Insiders In December 2021

Insiders are buying these penny stocks during "tax loss season" The post Penny Stocks To Buy Now According To Insiders In December 2021 appeared first on Penny Stocks to Buy, Picks, News and Information...

Other symbols:AMRXVEROXSPA
1 month ago - PennyStocks

New Accelerate Pheno® System Multi-Center Study Published in Clinical Infectious Diseases

TUCSON, Ariz., Nov. 22, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the publication of its Improving Outcomes and Antibiotic Stewardship (IOAS) Study in the journal ...

2 months ago - PRNewsWire

Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 57.14% and -11.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Accelerate Diagnostics Reports Third Quarter 2021 Financial Results

TUCSON, Ariz., Nov. 9, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced preliminary financial results for the third quarter for the period ended September 30, 2021, which...

2 months ago - PRNewsWire

Earnings Preview: Accelerate Diagnostics (AXDX) Q3 Earnings Expected to Decline

Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

Are These 2 Companies Next for Short Squeezes?

SmileDirectClub and Accelerate Diagnostics are super cheap right now, with very high short positions. Here's why the shorts might rupture.

Other symbols:SDC
3 months ago - The Motley Fool

Accelerate Diagnostics Schedules Call to Review 3rd Quarter 2021 Results

TUCSON, Ariz., Oct. 19, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Tuesday, November 9, 2021, at 4:30 p.m.

3 months ago - PRNewsWire

Accelerate Diagnostics Announces Agreements to Exchange Approximately $51 Million in Principal Amount of Its 2.50% Co...

TUCSON, Ariz., Sept. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that it has entered into separate, privately negotiated exchange agreements with certain holders...

4 months ago - PRNewsWire

Accelerate Diagnostics Reports Second Quarter 2021 Financial Results

TUCSON, Ariz., Aug. 5, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2021.

5 months ago - PRNewsWire

Accelerate Diagnostics Announces CE Mark and Availability in Europe of Fast Antimicrobial Susceptibility Test for Use...

TUCSON, Ariz., Aug. 3, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the new IVD configuration of its Accelerate PhenoTest® BC kit has been CE marked and is ready ...

5 months ago - PRNewsWire

This In Vitro Diagnostics Company Is Poised to Capture Its Share of a Growing Market

Its new system marks a groundbreaking advance in the field of testing for bloodstream infections.

5 months ago - The Motley Fool

Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

5 months ago - Zacks Investment Research

Accelerate Diagnostics Schedules Call to Review 2nd Quarter 2021 Results

TUCSON, Ariz., July 15, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 5, 2021, at 4:30 p.m.

6 months ago - PRNewsWire

Up 6% in June, Is Accelerate Diagnostics a Good Buy Now?

Investors were encouraged by a recent award the company received in the effort to diagnose and treat sepsis more rapidly.

6 months ago - The Motley Fool

Accelerate Diagnostics Launches a Fast Antimicrobial Susceptibility Test for Use with Existing ID Systems in the Unit...

TUCSON, Ariz., July 7, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the launch of a new IVD configuration of its Accelerate PhenoTest® BC kit in the United States.

6 months ago - PRNewsWire

New Accelerate Pheno® Landmark Study Validates Important Clinical Benefits to Be Presented at ECCMID 2021

TUCSON, Ariz., June 30, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that it will have 3 data presentations from its Improving Outcomes and Antibiotic Stewardship (IOA...

6 months ago - PRNewsWire

New Strong Sell Stocks for June 2nd

BEP, AXDX, FURY, KBAL, and LUNA have been added to the Zacks Rank #5 (Strong Sell) List on June 2, 2021

Other symbols:BEPFURYKBALLUNA
7 months ago - Zacks Investment Research

New Strong Sell Stocks for May 20th

AXDX, CRIS, FSTR, GO, and PRLB have been added to the Zacks Rank #5 (Strong Sell) List on May 20, 2021

Other symbols:CRISFSTRGOPRLB
8 months ago - Zacks Investment Research

Accelerate Diagnostics to Participate in William Blair 41st Annual Growth Stock Conference on June 3, 2021

TUCSON, Ariz., May 19, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief Executive Officer, Jack Phillips, and Chief Financial Officer, Steve Reichling, will pr...

8 months ago - PRNewsWire

New Strong Sell Stocks for May 14th

AXDX, CDR, FPAY, GCI, and IRTC have been added to the Zacks Rank #5 (Strong Sell) List on May 14, 2021

Other symbols:CDRFPAYGCIIRTC
8 months ago - Zacks Investment Research

Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -24.24% and -29.07%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

Accelerate Diagnostics Reports First Quarter 2021 Financial Results

TUCSON, Ariz., May 6, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the first quarter for the period ended March 31, 2021.

8 months ago - PRNewsWire